N
Noralane M. Lindor
Researcher at University of Rochester
Publications - 4
Citations - 828
Noralane M. Lindor is an academic researcher from University of Rochester. The author has contributed to research in topics: Microsatellite instability & Loss of heterozygosity. The author has an hindex of 4, co-authored 4 publications receiving 789 citations.
Papers
More filters
Journal ArticleDOI
Immunohistochemistry Versus Microsatellite Instability Testing in Phenotyping Colorectal Tumors
Noralane M. Lindor,Lawrence J. Burgart,Olga Leontovich,Richard M. Goldberg,Julie M. Cunningham,Daniel J. Sargent,Catherine Walsh-Vockley,Gloria M. Petersen,Michael Walsh,Barbara A. Leggett,Joanne P. Young,Melissa A. Barker,Jeremy R. Jass,John L. Hopper,Steve Gallinger,Bharati Bapat,Mark Redston,Stephen N. Thibodeau +17 more
TL;DR: IHC in colorectal tumors for protein products hMLH1 and hMSH2 provides a rapid, cost-effective, sensitive, and extremely specific method for screening for DNA mismatch repair defects.
Journal ArticleDOI
Birt‐Hogg–Dube Syndrome: an autosomal dominant disorder with predisposition to cancers of the kidney, fibrofolliculomas, and focal cutaneous mucinosis
TL;DR: The proband was evaluated for abdominal pain at age 61’years and found to have bilateral solid renal masses and underwent a partial left nephrectomy, and histologically both tumors contained both clear and granular cell types.
Journal ArticleDOI
p73 mutations are not detected in sporadic and hereditary breast cancer
David I. Schwartz,Noralane M. Lindor,Cate Walsh-Vockley,Patrick C. Roche,Ming Mai,David I. Smith,Wanguo Liu,Fergus J. Couch +7 more
TL;DR: Mutation analysis of 29 hereditary breast cancer cases revealed five independent silent mutations in the hereditary cases that are unlikely to play a role in tumor development, and mutations inThe p73 gene appear to play little if any role in hereditary or sporadic breast cancer.
Journal ArticleDOI
Colorectal Tumour Microsatellite Instability Test Results: Perspectives from Patients
Noralane M. Lindor,Jeff A. Sloan,Richard M. Goldberg,Deborah J. Bowen,Sandra Nigon,Amber Roche,Gloria M. Petersen,Stephen N. Thibodeau,Laurence Burgart,Olga Leontovich,Bruce W. Morlan +10 more
TL;DR: Individuals with colorectal cancer had a high level of interest in learning their individual MSI/IHC test results and did not seem deterred by the inherent complexity or ambiguity of this information.